Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphorylase b kinase (PhK) is a large, multi-subunit serine/threonine-specific protein kinase that plays a central role in glycogen metabolism. Its primary function is to activate glycogen phosphorylase by phosphorylation, thereby initiating the breakdown of glycogen into glucose-1-phosphate. The holoenzyme consists of 16 subunits arranged as four copies each of alpha (α), beta (β), gamma (γ), and delta (δ) subunits. The γ subunit provides the catalytic activity, while the α, β, and δ subunits are regulatory; the δ subunit is identical to calmodulin and binds calcium ions. PhK activity is tightly regulated through allosteric regulation by calcium ions, covalent modification by PKA-mediated phosphorylation, and autophosphorylation. It is highly expressed in liver and muscle cells, supporting immediate energy needs during contraction and maintaining blood glucose levels. Defects in any component can lead to metabolic disorders affecting energy balance.
Phosphorylation of glycogen phosphorylase b to activate it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphorylase b Kinase (PhK).